Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
HCPCS Code

HCPCS code C1728 – Brachytherapy seed catheter


Code Definition

C1728 is the HCPCS Level II code for catheter, brachytherapy seed administration. Hospitals report it on the outpatient claim when catheters carry radioactive seeds or sources to the treatment site.

CMS assigns C1728 status indicator N under OPPS, so its cost is packaged into the placement procedure, such as CPT 55875. The radioactive sources are billed on their own lines and paid separately.

Level
Level II
Category
C — Temporary codes for the outpatient prospective payment system (OPPS)
Status
N — packaged under OPPS (October 2026)
Billable
No
Code also known as
Cath, brachytx seed adm
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS Code C1728 reports a catheter used to deliver brachytherapy seeds or sources, billed by hospitals on the outpatient UB-04 claim.

The October 2026 OPPS Addendum B lists C1728 with status indicator N, so its cost is packaged into the placement procedure.

Pass-through payment for C1728 expired on December 31, 2002, but CMS still expects hospitals to report the device code.

The radioactive seeds are billed on their own lines, per source, under codes such as C2638, and CMS pays them separately.

Pabau, the practice management platform we build, keeps device details, consent forms, and treatment notes on one patient record, so the claim matches the chart.

HCPCS Code C1728: What the brachytherapy catheter code covers

HCPCS Code C1728 is the Level II code for “Catheter, brachytherapy seed administration.” It reports the catheter used to carry radioactive seeds or sources to the treatment site during brachytherapy. Hospitals list it on the outpatient claim beside the procedure that placed the catheters.

The CMS HCPCS file gives C1728 an add date of April 1, 2001, and the short descriptor “Cath, brachytx seed adm.” Because C1728 describes a device, it always travels with the CPT code for the placement.

Check the current descriptor on CMS’s HCPCS code set page each quarter. Hospital coders can look up neighboring codes in our HCPCS reference for coders.

Attribute Detail
Code C1728
Official descriptor Catheter, brachytherapy seed administration
Short descriptor Cath, brachytx seed adm
Code series HCPCS Level II C-codes, used under the hospital outpatient prospective payment system (OPPS)
Added to HCPCS April 1, 2001
OPPS status indicator N (packaged into the procedure payment, October 2026 Addendum B)
ASC payment indicator N1 (packaged, no separate ASC payment, October 2026 ASC addenda)
Pass-through status Expired December 31, 2002
Claim form UB-04 (CMS-1450), hospital outpatient bill type 12X or 13X

What a brachytherapy seed administration catheter does

Brachytherapy treats cancer by placing radioactive sources inside the tumor or right next to it. The sources reach the site through needles or catheters placed by the radiation oncologist or surgeon.

A catheter is a flexible tube, so it can follow a path that a rigid needle cannot. C1728 covers the catheter. A brachytherapy needle has its own code, C1715.

Several CPT codes describe placing “needles or catheters” for interstitial radioelement application. The most common sites are these:

  • Prostate: CPT 55875, transperineal placement
  • Pelvic organs and genitalia other than the prostate: CPT 55920
  • Muscle and soft tissue: CPT 20555
  • Head and neck: CPT 41019, which also allows other devices

Each of those descriptors allows needles or catheters, so the CPT code never tells you which device to report. The operative note does, and it decides between C1728 and C1715.

Where C1728 belongs on the claim

C1728 belongs on the hospital outpatient claim, the UB-04 that OPPS hospitals submit under bill type 12X or 13X. Since January 1, 2005, CMS has required these hospitals to report device codes with the procedures that use them.

The physician who places the catheters bills the CPT code alone on a CMS-1500. C-codes describe the facility’s device cost, so they stay off the professional claim.

An ambulatory surgical center can report C1728 as well. The October 2026 ASC addenda list it with payment indicator N1, so the catheter is packaged and earns no separate ASC payment.

Inpatient stays follow different rules. Device costs on an inpatient claim roll into the MS-DRG payment, so C1728 has no line there.

How C1728 is paid under OPPS

C1728 earns no separate payment under Medicare OPPS. The October 2026 OPPS Addendum B lists it with status indicator N, so its cost is packaged into the procedure that used the catheter.

Pass-through payment expired on December 31, 2002, per Chapter 4 of the Medicare Claims Processing Manual. Hospitals must still report the code when they use the device. The placement procedures carry the payment instead, mostly through comprehensive APCs with status indicator J1.

Code What it reports Status indicator APC and national unadjusted rate (October 2026)
C1728 Catheter, brachytherapy seed administration N Packaged; no separate rate
55875 Transperineal placement of needles or catheters into the prostate for interstitial radioelement application J1 APC 5375, $5,477.93
55920 Placement of needles or catheters into pelvic organs or genitalia, except the prostate, for interstitial radioelement application J1 APC 5415, $5,110.80
20555 Placement of needles or catheters into muscle or soft tissue for interstitial radioelement application J1 APC 5113, $3,342.87
41019 Placement of needles, catheters, or other devices into the head or neck for interstitial radioelement application J1 APC 5165, $6,048.05
77778 Interstitial radiation source application, complex S APC 5624, $711.56
C2638 Brachytherapy source, stranded, iodine-125, per source U APC 2638, $35.26 per source

These are national unadjusted Medicare rates. Wage index and commercial contracts shift what you are paid.

Sources are the exception. CMS pays brachytherapy sources separately under status indicator U, per section 61.4 of the claims manual.

Packaged does not mean optional. CMS uses device charges to set future APC rates, so a missing C1728 line understates what the procedure costs.

No edit will flag a missing C1728, either. The placement codes fall below the 30 percent device offset for device-intensive status, so only your own audit catches it.

How to bill HCPCS Code C1728: Step-by-step instructions

Billing C1728 correctly means matching four things on the UB-04: the setting, the device, the placement code, and the sources. Error-checking claims management software catches most mismatches before the claim leaves the facility.

  1. Confirm the outpatient setting. Verify the patient is registered as a hospital outpatient, not an inpatient.
  2. Confirm the device was a catheter. Read the operative note for catheters rather than needles before you choose C1728 or C1715.
  3. Report the placement code. Add the CPT code for the site, such as 55875, 55920, 20555, or 41019.
  4. Enter C1728 with its units. Report one unit per catheter documented, with your chargemaster charge for each.
  5. Bill the sources on their own lines. Report each isotope under its source code, such as C2638, with units equal to the number of sources.
  6. Add the diagnosis. List the malignancy first, coded to the highest specificity the record supports.

For a prostate seed implant, the finished claim carries four kinds of line, and only two of them earn payment.

Claim map for a prostate seed implant
The C1728 line adds nothing to the payment, but CMS uses its charge to set future APC rates. Rates are from the CMS October 2026 OPPS Addendum B.

The billing field reference below maps each element to its UB-04 locator.

Field UB-04 locator What to enter
Revenue code FL 42 The device revenue code in your chargemaster, usually 0272 (sterile supply) or 0278 (other implants)
HCPCS code FL 44 C1728 on the device line; the CPT placement code and each source code on their own lines
Service date FL 45 Date the catheters were placed
Units FL 46 One per catheter documented; one per source on each source line
Charges FL 47 Your chargemaster charge for the catheters
Diagnosis codes FL 67 The ICD-10-CM code for the malignancy being treated, listed first

Pro Tip

Map every brachytherapy catheter in your supply catalog to C1728 and every needle to C1715, then audit the mapping each quarter. Most device-line errors on these cases start in the chargemaster, not with the coder.

Documentation requirements for C1728 claims

Every C1728 line needs a record that shows catheters were used, how many, and why. Strong medical billing compliance builds that record during the case rather than after a denial arrives.

  • Operative or procedure note naming catheters rather than needles, the number placed, and the treatment site
  • Device labels or Unique Device Identifiers (UDIs) for the catheters, filed in the medical record
  • Source records listing the isotope, stranded or non-stranded form, and the number of sources ordered and implanted
  • The radiation oncologist’s treatment plan, including the prescribed sources
  • Imaging guidance notes when ultrasound or other imaging guided the placement
  • Prior authorization where a commercial payer requires it

CMS lets hospitals bill a small number of sources that were ordered but not implanted. The record must show they were acquired for that patient, never used for anyone else, and disposed of properly.

Most C1728 errors come from mixing up the device, the source, and the service. The table below compares the codes most often confused with it.

Code What it describes How it differs from C1728
C1728 Catheter, brachytherapy seed administration Use when catheters carry the sources to the treatment site
C1715 Brachytherapy needle Use when needles, not catheters, were placed; also packaged (status indicator N)
C2638 Brachytherapy source, stranded, iodine-125, per source The radioactive seed itself, paid separately per source
C1717 Brachytherapy source, non-stranded, high dose rate iridium-192, per source The high dose rate source, not the catheter it travels through
77790 Supervision, handling, loading of radiation source A packaged service charge (status indicator N), never a device line
C1778 Lead, neurostimulator (implantable) A neurostimulator lead, unrelated to brachytherapy
C1889 Implantable/insertable device, not otherwise classified Only for devices with no specific code; C1728 already describes the catheter

Needle-only cases are the classic trap. When the operative note describes needles and no catheters, the device line takes C1715 instead.

Some older references tie C1728 to neurostimulators, which is wrong. A neurostimulator lead is C1778, and a neurostimulator test kit lead is C1897.

Verify neighboring descriptors in the current CMS HCPCS file before you code. Never choose a code from memory or from last year’s claim.

Common C1728 claim denials and how to avoid them

C1728 rarely causes a denial on its own, because it carries no separate payment. The costly errors sit around it, in the placement and source lines. Good denial management workflows trace each one to a root cause before anyone resubmits.

Problem Root cause Prevention step Fix
Catheter missing from the claim The chargemaster or supply capture did not drop the device line Map brachytherapy catheters to C1728 in the chargemaster Submit a corrected claim with C1728 added
Needles coded as catheters C1728 reported when the operative note shows needles Read the operative note for the device type before coding Correct the device line to C1715
Sources missing or undercounted Source lines left off, or units not matched to the count Bill each source code with units equal to the sources used Submit a corrected claim with the source lines
Device code on the physician claim C1728 billed on a CMS-1500 Keep C-codes on the facility claim only Remove the C-code from the professional claim
Device line with no procedure C1728 reported without a placement code Pair the device with its CPT code on the same claim Add the procedure line and resubmit
Wrong first-listed diagnosis Z51.0 sequenced first on a brachytherapy encounter List the malignancy first, as the coding guidelines require Resequence the diagnoses and resubmit

When a denial arrives, read the electronic remittance advice first. The Claim Adjustment Reason Code (CARC) and Remittance Advice Remark Code (RARC) together identify the exact reason.

Pro Tip

Before a brachytherapy claim goes out, check four things. Is the patient registered as an outpatient? Does the operative note say catheters or needles? Are the placement code, C1728, and every source line on the claim? Is the malignancy listed first?

ICD-10 diagnosis codes commonly paired with C1728

The diagnosis on a C1728 claim is the cancer being treated. The FY 2027 ICD-10-CM Official Guidelines say an encounter for implanting radioactive elements lists the malignancy first. They add that Z51.0 should not be assigned.

External beam radiation works the other way, with Z51.0 as the first-listed code. A biller who carries that habit over to brachytherapy puts the wrong code first.

ICD-10-CM code Description When it fits
C61 Malignant neoplasm of prostate Prostate seed implant placed under CPT 55875
C53.9 Malignant neoplasm of cervix uteri, unspecified Interstitial gynecologic brachytherapy placed under CPT 55920
C54.1 Malignant neoplasm of endometrium Interstitial pelvic brachytherapy for endometrial cancer
C52 Malignant neoplasm of vagina Interstitial vaginal brachytherapy placed under CPT 55920
C49.9 Malignant neoplasm of connective and soft tissue, unspecified Soft tissue sarcoma treated with catheters placed under CPT 20555
C02.9 Malignant neoplasm of tongue, unspecified Head and neck brachytherapy placed under CPT 41019

On a prostate seed implant, the first-listed code is usually C61. Use the most specific code the documentation supports. Where the code set offers a more precise site or laterality, the unspecified code is the wrong choice.

How Pabau keeps brachytherapy device details on the patient record

Brachytherapy claims go wrong at the point of capture. Seed counts sit on one worksheet, catheter labels sit in a folder, and the coder sees neither.

Pabau keeps consent forms, treatment notes, photos, and custom device fields on one patient record. Staff record catheter and source details while the case is still open.

Our claims and billing tools sit on that same record. When an auditor asks how many catheters and seeds you used, the answer is already in the file.

Keep catheter and seed details on one record

Pabau brings consent forms, treatment notes, and custom device fields onto one patient record. Your team documents catheters and sources once, so coders and auditors find what they need without chasing paper.

Pabau practice management dashboard

Conclusion

C1728 will not change your OPPS payment for a brachytherapy placement, because CMS packages the catheter into the procedure. Its value lies in the cost data and the evidence trail. No device edit flags a missing C1728, so the habit has to live in your chargemaster.

Read the operative note for catheters or needles, bill every source with the right units, and put the malignancy first. Book a demo to see how Pabau keeps device details, notes, and consent on one patient record.

Continue your research

Continue your research

Need to understand how clean claims reduce your denial rate? Clean claim submission guide covers the elements every facility claim must include before submission to avoid preventable rejections.

Confused about how denial codes map to corrective actions? Denial codes in medical billing provides a full reference to CARC and RARC codes with corrective action guidance.

Want to see how HCPCS billing fits into the broader revenue cycle? What is medical billing? explains the end-to-end process from charge capture to payment posting.

Frequently asked questions

What does HCPCS Code C1728 cover?

HCPCS Code C1728 covers a catheter used to deliver brachytherapy seeds or sources to a treatment site. Hospitals report it on the outpatient UB-04 claim beside the CPT code for the catheter placement.

Is C1728 a pass-through code?

No. Its pass-through status expired on December 31, 2002. The October 2026 OPPS Addendum B lists C1728 with status indicator N, so its cost is packaged into the placement procedure.

Which CPT codes are billed with C1728?

C1728 pairs with CPT codes that place needles or catheters for interstitial radioelement application. Common examples are 55875 for the prostate, 55920 for other pelvic sites, 20555 for soft tissue, and 41019 for the head and neck.

What is the difference between C1728 and C1715?

C1728 reports a brachytherapy catheter, while C1715 reports a brachytherapy needle. The operative note decides which one applies, because the placement CPT codes allow either device.

Are the brachytherapy seeds included in C1728?

No. Seeds and other radioactive sources are billed on their own lines under source codes, such as C2638 for stranded iodine-125. CMS pays them per source, so the units must match the number used.

Should Z51.0 be the first diagnosis on a C1728 claim?

No. The ICD-10-CM guidelines say an encounter for implanting radioactive elements lists the malignancy first, and Z51.0 should not be assigned. Z51.0 belongs on encounters chiefly for external beam radiation therapy.

×